172 related articles for article (PubMed ID: 28721844)
1. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
[TBL] [Abstract][Full Text] [Related]
2. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
3. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus entry and the tetraspanin CD81.
Farquhar MJ; Harris HJ; McKeating JA
Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934
[TBL] [Abstract][Full Text] [Related]
5. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
[TBL] [Abstract][Full Text] [Related]
6. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.
Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT
J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820
[TBL] [Abstract][Full Text] [Related]
7. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
8. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
[TBL] [Abstract][Full Text] [Related]
10. Diverse CD81 proteins support hepatitis C virus infection.
Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
Mekky RY; El-Ekiaby N; El Sobky SA; Elemam NM; Youness RA; El-Sayed M; Hamza MT; Esmat G; Abdelaziz AI
Arch Virol; 2019 Jun; 164(6):1587-1595. PubMed ID: 30949812
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.
Alberione MP; Moeller R; Kirui J; Ginkel C; Doepke M; Ströh LJ; Machtens JP; Pietschmann T; Gerold G
Med Microbiol Immunol; 2020 Aug; 209(4):499-514. PubMed ID: 32322956
[TBL] [Abstract][Full Text] [Related]
13. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
[TBL] [Abstract][Full Text] [Related]
14. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
15. Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins.
Kalemera MD; Capella-Pujol J; Chumbe A; Underwood A; Bull RA; Schinkel J; Sliepen K; Grove J
J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33147126
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Structural Tuning of the Hepatitis C Virus Human Cellular Receptor CD81 Large Extracellular Loop.
Cunha ES; Sfriso P; Rojas AL; Roversi P; Hospital A; Orozco M; Abrescia NGA
Structure; 2017 Jan; 25(1):53-65. PubMed ID: 27916518
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into hepatitis C virus receptor binding and entry.
Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.
Rajesh S; Sridhar P; Tews BA; Fénéant L; Cocquerel L; Ward DG; Berditchevski F; Overduin M
J Virol; 2012 Sep; 86(18):9606-16. PubMed ID: 22740401
[TBL] [Abstract][Full Text] [Related]
19. Two methods of heterokaryon formation to discover HCV restriction factors.
Frentzen A; Hueging K; Bitzegeio J; Pietschmann T; Steinmann E
J Vis Exp; 2012 Jul; (65):e4029. PubMed ID: 22825033
[TBL] [Abstract][Full Text] [Related]
20. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
